Activation of Rat Intestinal Alkaline Phosphatase by Taurine May be an Alternative Mechanism of Endotoxemic Injury Protection by Arise, RO et al.
Available online at http://www.ajol.info/index.php/njbas/index  
Nigerian Journal of Basic and Applied Science (June, 2015), 23(1): 55-64 
DOI: http://dx.doi.org/10.4314/njbas.v23i1.9  
ISSN 0794-5698 
 
Activation of Rat Intestinal Alkaline Phosphatase by Taurine May be an Alternative Mechanism of 
Endotoxemic Injury Protection 
 
*R.O. Arise, A. Igunnu, A. Olajunyin, O.S. Akiode and O.J. Olatomiwa  
Drug Development & Enzymology Research Unit, Department of Biochemistry,  
Faculty of Life Sciences, P.M.B.1515, University of Ilorin, Ilorin, Nigeria. 





















ABSTRACT: Investigation of the effect of taurine on the hydrolysis of para-nitrophenylphosphate (p-NPP) by rat 
intestinal alkaline phosphatase (ALP), L-phenylalanine inhibition of ALP and the mechanism of ALP activation by 
taurine as well as its role in endotoxemic injury protection was carried out. Rat intestinal ALP was exposed to taurine, 
and L-phenylalanine at varying concentrations and periods of time. Substrate concentration-dependent kinetic 
analysis was carried out at 10 mM concentration of taurine and 5.17mM of p-NPP. The concentration dependent 
kinetic analysis of L-phenylalanine was also investigated at 60 mM. The partially purified rat intestinal alkaline 
phosphatase activity was also investigated in the presence of taurine. Their interactive effect on L-phenylalanine 
inhibition was also analyzed. Investigation of the effect of taurine on rat intestinal ALP hydrolysis of p-NPP revealed 
that taurine is an activator of intestinal ALP. At 10 mM taurine and 60 mM L-phenylalanine, taurine relieved L-
phenylalanine inhibition of rat intestinal ALP. The effect of lipopolysaccharide in the absence and presence of taurine 
on ALP activity was also carried out in vivo. The kinetic analysis of the data from the in vivo study revealed that rat 
intestinal ALP activity is higher (12x10-3nmol-1min-1mg protein) in the presence of taurine and LPS when compared 
with the activity in the presence of LPS (9x10-3nmol-1min-1mg protein) or taurine (8.8x10-3nmol-1min-1mg protein) 
alone. From this study, it may be concluded that the activation of rat intestinal ALP by taurine may be one of the 
mechanisms of endotoxemic injury protection. 
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INTRODUCTION 
Lipopolysaccharide (LPS), also known as endotoxin, 
plays a major role in the development and/or aggravation 
of several multifactoral diseases, including sepsis, 
atherosclerosis, inflammatory bowel disease, rheumatoid 
arthritis, and multiple sclerosis (Gardiner et al., 1995; 
Patel et al., 1995; Vincent et al., 2002). It is a major 
constituent of the outer leaflet of the Gram-negative 
bacteria cell membrane and a single bacterial cell 
contains approximately 3.5 x 106 LPS molecules, which 
are essential for growth and stability of the bacterium 
(Rietschel et al., 1994).  A full length LPS molecule 
consists of four different parts: a lipid A moiety, an inner 
core, an outer core, and an O-antigen (Raetz, 1990). 
The lipid A moiety of LPS is composed of two 
phosphorylated glucosamine saccharides linking at least 
six fatty acids. This part is the toxic component of the 
molecule, since injection of a chemically synthesized 
lipid A induces effects in vivo similar to an injection with 
a full length LPS molecule (Galanos et al., 1985; Kotani 
et al., 1985).  
 
The two phosphate groups attached to the saccharides 
are essential for the toxic activity of lipid A. Removal of 
one phosphate group results in the formation of 
monophosphoryl lipid A (MPLA), which has a significant 
reduced bioactivity compared to lipid A (Loppnow et al., 
1989; Schromm et al., 2000; Gangloff et al., 2005). 
Alkaline phosphatase (ALP) functions as a host defense 
molecule at physiologic pH when endotoxin is used as a 
substrate,  and is present in many cells and 
organs and abundant in kidney tissue. In several animal 
studies, exogenous administration of ALP resulted in 
attenuation of the inflammatory response induced by 
gram-negative bacteria and lipopolysaccaride (LPS) and 
reduced mortality (Chen et al., 2010). It is suggested that 
upregulation of endogenous glomerular ALP reflects a 
local host defense principle against LPS in the kidney, 
and that ALP can be inactivated by reacting oxygen 
species and peroxynitrite generated during sepsis (Li 
and Shah, 2004). Additionally, the expression of iNOs 
protein levels correlates negatively with the activity of 
ALP in duodenum of rats exposed to LPS (Munford, 
2005). There has been emerging evidence for the 
functional role of intestinal alkaline phosphatase (IALP) 
as a detoxifying enzyme for lipopolysaccaride (Goldberg 
et al., 2008). Intestinal alkaline phosphatase activity has 
been associated with the reduction of inflammatory 
conditions in the bowel (Goldberg et al., 2008). Exposure 
of intestinal wall to LPS induces IALP gene expression. 
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IALP detoxifies LPS by removing its phosphate esters in 
vitro. Inhibitors of alkaline phosphatase activity have 
been used in shedding more light on the physiological 
role of the enzyme which is still elusive (Shirazi et al., 
1981; Cyboron et al., 1982). 
 
Phenylalanine is a known inhibitor of alkaline 
phosphatase (Malomo et al., 2003) and it is believed to 
have some roles in inflammatory response (Campbell et 
al., 2010). The immune system during microbial invasion 
is generally protective, septic shock develops in a 
number of patients as a consequence of excessive or 
poorly regulated immune response to the offending 
organism (Gram-negative or Gram-positive bacteria, 
fungi, viruses, or microbial toxins) (Klosterhalfen et al., 
1992). Many mechanisms are involved in the 
pathogenesis of septic shock, including the release of 
cytokines (Ulloa and Tracey, 2005), the activation of 
neutrophils (Yuo et al., 1991), monocytes and 
microvascular endothelial cells (Gougerot Podicalo et al., 
1996), as well as the activation of neuroendocrine 
reflexes (Van den Berghe et al.,1998) and plasma 
protein cascade systems, such as the complement 
system (Sprung et al., 1986), the intrinsic and extrinsic 
pathways of coagulation and the fibrinolytic system 
(Corrigan et al., 1968).  
 
Although the lipopolysaccharide of the gram negative 
bacterial wall (endotoxin) and the peptidoglycan of gram-
positive bacterial wall are the most extensively studied 
(Ahmed and Christou, 1996), several other agents, like 
the formyl-peptide, formylmethionyl- leucyl-phenylalanine 
(FMLP), also promote the inflammatory response 
(Becker, 1987). Phenylalanine is a component of the 
bacterial N-formyl peptides, such as N-formyl-Met-Leu-
Phe (fMLF), which is the first identified and most potent 
chemo attractant for phagocytic leukocytes (Marasco et 
al., 1984). FMLP induces activation of leukocytes, 
initiates chemotaxis, stimulates cell aggregation, enzyme 
secretion, arachidonic acid and oxidative metabolism 
(Tiffany et al., 2001), and causes systemic hypotension 
associated with a decrease in systemic vascular 
resistance (Jonsson et al., 1997). 
 
Alkaline phosphatase on the other hand is a dimeric 
metalloenzyme that can be activated or inhibited by 
modifiers. However, taurine has been reported to 
activate ALP, outside its two important metal ions; Mg2+ 
and Zn2+. Taurine has been reported to be the most 
abundant sulphonic amino acid found in the small 
intestine (Huxtable, 1992) and an inhibitor of intestinal 
translocation (Wang, 1995). It is also known to protect 
against endotoxemic injury (Wang, 1995). The 
mechanism of this endotoxemic protection might be 
linked to taurine interaction with alkaline phosphatase. 
Thus, this study was carried out to investigate the effect 
of taurine on the hydrolysis of para-nitrophenyl 
phosphate (p-NPP) by rat intestinal ALP, L-
phenylalanine inhibition of ALP and the mechanism of 
activation as well as the role of taurine in endotoxemic 
injury protection. And to investigate whether this 
phenomenon can be employed in further strengthening 
the defense against LPS toxicity by ALP’s ability to 
detoxify it through dephosphorylation. 
 
MATERIALS AND METHODS 
Reagents, chemicals, and enzyme source 
ALP substrate, the sodium salt of para-nitrophenyl 
phosphate (p-NPP) and lipopolysaccharide were 
obtained from Sigma Chemical Company, St. Louis, US. 
Magnesium sulphate, L-phenylalanine, sodium ortho-
vanadate, sodium hydroxide, sodium hydrogen 
carbonate and anhydrous sodium carbonate, taurine 
were all products of BDH  Laboratory Reagents, Poole 
England. All other chemicals used in this study were of 
high quality research grade. The tissue-specific ALP 
used here was obtained from the intestines of two albino 
rats (Rattus novergicus) among those obtained from 
small Animal Holding Unit of the Department of 
Biochemistry, University of Ilorin, Ilorin, Nigeria. 
 
Preparation of Rat Tissue Homogenate 
Fresh intestinal tissue from Rattus novergicus was 
homogenized in 0.25 M sucrose solution at 4°C and the 
crude homogenate was centrifuged at 4000 rpm for 20 
minutes at the same temperature. The supernatant was 
collected and dispensed in Eppendorf tubes and stored 
frozen. Fresh aliquots were used each day for the 
experiments described in this report. It is generally 
believed that to perform a large number of kinetic 
measurements under constant conditions it is more 
important to have large stabilized enzyme preparations 
than small preparations with a higher activity (Ahlers, 
1975). Thus, we did not attempt further purification since 
the enzyme is unusually stable even in impure crude 
preparations (Garen and Levinthal, 1960). The key 
experimental results obtained with the crude ALP extract 
were validated with homogenous calf intestinal ALP 
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Determination of ALP-Catalysed Hydrolysis of P-NPP 
Alkaline phosphatase activity was measured by the rate 
of hydrolysis of appropriate concentrations of p-
nitrophenylphosphate (pNPP) at 25°C in 0.1 M 
Na2CO3/NaHCO3 buffer, pH 10.1 as previously described 
(Ahlers, 1975). Enzyme activity is expressed as the 
mMol of p-nitrophenol released per minute. Reaction 
mixtures containing the enzyme source and buffers in 
the presence of the appropriate concentrations of the 
modifiers (magnesium, taurine, vanadate, and L-
phenylalanine) were kept at 25 °C for 10 minutes. In all 
assays, 100 µl of the crude enzyme preparation 
equivalent to 0.5 mg total protein were added to catalyse 
the hydrolysis of p-NPP. Reactions were initiated by the 
addition of the appropriate concentration of the 
substrate, p-NPP. Incubation was allowed for 10 minutes 
before stopping the reaction by the addition of 0.35 M 
NaOH. The absorbance was read at 400 nm against a 
blank of the buffered substrate on a Spectronic-21 UV 
Vis spectrophotometer and the corresponding activities 
recorded. All measurements of reaction rate were 
performed in triplicate. Protein concentration was 
determined using Biuret method (Gornall et al., 1949).  
 
In Vivo Effect of LPS and/ or Taurine on ALP Activity 
To investigate the effect of LPS on ALP activity, 1ml of 
LPS (0.5mg/ml) was administered to a set of rat 
intraperitoneally (group 1) and the effect on the rats was 
observed for 20 minutes after which the rats were 
sacrificed through cervical dislocation. The small 
intestines were collected and the kinetics of ALP 
investigated. The p-NPP concentration used was 
5.17mM. The Km and Vmax values were consequently 
estimated. To investigate the effect of LPS and taurine 
on ALP activity, 1ml of taurine (4.8mg/ml) was first 
administered to the rats orally and the rats were left for 
20 minutes after which 1ml LPS (0.5mg/ml) was 
administered to each rat intraperitoneally. The effect on 
the rats was observed for few minutes after which the 
rats were sacrificed through cervical dislocation. The 
liver and intestine were collected and the kinetics of ALP 
activity investigated. The p-NPP concentration used was 




Activation of ALP by Mg2+ and taurine 
An analysis of the roles of Mg2+ ions and taurine in the 
activation of ALP was carried out by investigating the 
kinetics of p-NPP hydrolysis in the presence of 0 and 40 
mM concentrations of the metal ion (Figure 1A) and 0 
and 10 mM concentrations of taurine (Figure 2B). In 
experiments to determine kinetic constants, activity was 
monitored by measuring the absorbance change at 
varying substrate concentrations (0.2–1.8 mM p-NPP) in 
the presence of varying ligand concentrations. The 
effects of Mg2+ and taurine on the Km for pNPP and Vmax 
values were obtained from Lineweaver-Burk plots 
(Figures 1B and 2B; Table 1). Within the range of 
substrate concentration examined, the hydrolysis of 
pNPP by ALP followed saturation kinetics (Figures 1 and 
2). Kinetic analysis showed that both Mg2+ and taurine 
activate ALP catalyzed p-NPP by increasing the 
maximum reaction rate (Vmax) as shown in Table 1. The 
activation of alkaline phosphatase by Mg2+ and taurine 
was also accompanied by a change in the Michaelis 
constant (Km).  
 
Inhibition of rat intestinal ALP by L-phenylalanine 
The Michaelis–Menten’s curve and the double reciprocal 
plot for the hydrolysis of p-NPP over a range of 
concentrations by alkaline phosphatase in the presence 
of 60 mM L-phenylalanine are shown in Figures 3A and 
3B. The values of kinetic parameters, Vmax and Km are 
given in Table 1. There was an evidence of inhibition of 
ALP activity when exposed to 60 mM L-phenylalanine as 
indicated by sharp drop in the Vmax. 
 
Interaction of Taurine with Mg2+ and Phenylalanine 
on Rat Intestinal Alkaline Phosphatase 
Results presented in Figures 1 and 2 show that both 
Mg2+ and taurine are required for ALP activation. Hence, 
we sought to determine if any synergistic interactions 
exist between both ligands in the activation of ALP, and 
to determine the optimal concentrations of both ligands 
for full activity. The effects of Mg2+ and taurine on ALP 
activity were investigated by determining the rate of 
hydrolysis of 5.17 mM pNPP in the presence of 10 mM 
taurine and 40 mM  Mg2+. The results of this experiment 
are shown in Figure 4 and the pattern indicates a 
synergistic interaction between the two ligands as 
indicated by increase in the Vmax. The values of kinetic 
parameters, Vmax and Km are given in Table 1.  
 
The effect of interaction of 10 mM taurine and 60 mM L-
phenylalanine on rat intestinal alkaline phosphatase 
hydrolysis of p-NPP was also investigated and the result 
obtained is shown in Figure 5. The result shows that 
taurine modulates L-phenylalanine inhibition of rat 
intestinal ALP activity as indicated by increase in the 
Vmax (Table 1).  
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Interaction of Lipopolysaccharide (LPS), Taurine and 
a Combination of LPS and Taurine 
with Intestinal ALP Activity 
The Michaelis-Menten‘s curve and double reciprocal plot 
for effect of taurine, LPS and interaction of taurine and 
LPS on the hydrolysis of p-NPP over a range of 
concentration (0.207 – 1.861) by alkaline phosphatase is 
shown in Figures 5 and 6 respectively. The values of 
kinetic parameters Km and Vmax are given in Table 2. 
 
The kinetic analysis of the data revealed that rat 
intestinal ALP activity is highest in the presence of 
taurine and LPS combination when compared with the 
activity in the presence of LPS alone and taurine. The 
data showed only slight difference in the activity of ALP 
in the presence of LPS and taurine as depicted by the 
values of Vmax (Table 15). The presence of taurine and 
LPS affects the binding affinity (Km) of ALP for p-NPP. A 
low affinity is recorded in the presence of LPS when 
compared with the affinity in the presence of a 
combination of LPS and taurine alone. The highest 
affinity is observed in the presence of taurine only. This 
is deduced from low Km value (in the case of taurine 
only) and slightly different values of Km (in the presence 






Figure 1A: Kinetic analysis of the effects of Mg2+ on 
ALP-catalyzed hydrolysis of p-NPP.  
Figure 1B: Double reciprocal plot of the effects of Mg2+ 





Figure 2A: Kinetic analysis of the effects of taurine on 
ALP-catalyzed hydrolysis of p-NPP. 
Figure 2B: Double reciprocal plot the effects of taurine 
on ALP-catalyzed hydrolysis of p-NPP. 
 
Reaction mixture containing 0.1M Na2CO3/NaHCO3 buffer (pH 10.1) and 10 µl crude ALP (0.5 mg total protein) was pre-
incubated at 25 oC both in the absence of Mg2+ and in the presence of 40 mM Mg2+ for 10 minutes. Reaction was initiated by the 
addition of 0.2-1.8 mM p-NPP and incubation was carried out for 10 minutes before stopping the reaction by the addition of 1.0 ml 






















































Figure 3A: Kinetic analysis of the effects of L-phenylalnine on 
ALP-catalyzed hydrolysis of p-NPP. 
Figure 3B: Double reciprocal plot of the effects of L-
phenylalanine on ALP-catalyzed hydrolysis of p-NPP.  
 
 
Figure 4: Synergistic activation of ALP-catalyzed 
hydrolysis of p-NPP by Mg2+ and taurine. 
 
Figure 5: Kinetic analysis of the modulatory effect of taurine 
on L-phenylalanine inhibition of rat intestinal ALP 
activity. 
 
Reaction mixture containing 0.1M Na2CO3/NaHCO3 buffer (pH 10.1) and 10 µl crude ALP (0.5 mg total protein) was pre-incubated at 25 oC both in the 
absence of L-Phenylalanine and in the presence of 60 mM L-Phenylalanine for 10 minutes. Reaction was initiated by the addition of 0.2-1.8 mM p-NPP 
and incubation was carried out for 10 minutes before stopping the reaction by the addition of 1.0 ml 0.35 M KOH. Enzyme activity is expressed as the 


























Figure 6A: Michaelis-Menten curve of intestinal ALP activity 
following intra-peritoneal administration of rat with 
LPS, taurine, and taurine + LPS. 
 
Figure 6B: Double-reciprocal plot showing effect of taurine, 
LPS and a combination of both on the rate of 
intestinal ALP-catalyzed hydrolysis of p-NPP. 
 
Reaction mixture containing 0.1M Na2CO3/NaHCO3 buffer (pH 10.1) and 10 µl crude ALP (0.5 mg total protein) was pre-incubated at 25 oC both in the 
absence of L-Phenylalanine and in the presence of 60 mM L-Phenylalanine for 10 minutes. Reaction was initiated by the addition of 0.2-1.8 mM p-NPP 
and incubation was carried out for 10 minutes before stopping the reaction by the addition of 1.0 ml 0.35 M KOH. Enzyme activity is expressed as the 
mMol of para-nitrophenol released per minute 
Table 1: Kinetics Parameters of Rat Intestinal ALP in the 
Presence of Different Modifiers at 25 oC
 
Modifers 




No modifiers 7.80±0.18 0.29+0.01 
Mg2+  17.72±0.92 0.40±0.03 
Taurine 13.95±0.18 0.49±0.05 
L-Phe  3.94±0.18 0.60±0.20 
Taurine + Mg2+  19.63±0.05 0.25±0.15 
Taurine + L-Phe 6.85±0.05 1.93+0.04 
The values represent Vmax and Km of different modifiers of rat 
intestinal ALP and the standard deviation (n=3). 
 
Table 2: Kinetic Parameters of intestinal ALP after 
intraperitoneal administration of 
lipopolysaccharides (LPS) and taurine at 25 oC 
 Vmax  x10-3 
(nmol/min/mg protein) 
Km  x10-2   
  (mM) 
No modifier 6.79 27.8 
LPS only 9.0 38.0 
Taurine 8.8 23.00 
LPS + Taurine 12.0 22.0 
The values represent Vmax and Km of different modifiers of rat 
intestinal ALP and the standard deviation (n=3). 
 
DISCUSSION 
The activation of ALP by magnesium as observed is in 
conformity with earlier studies (Ahlers, 1974; Arise et al., 
2005). Magnesium may have occupied the structural site 
on ALP that led to a subsequent conformational change 
from a less active form of  ALP  to a more activated form 
of the enzyme (i.e. activated ALP–Mg2+ Complex). The 
activated ALP-Mg2+ complex has a low Km which shows 
that it has a high binding affinity for the substrate. The 
activated ALP- taurine complex has a low Km which 
shows that it has a high binding affinity for the substrate. 
Taurine may have occupied the structural site on ALP 
that led to a subsequent conformational change from a 
less active form of  ALP  to a more activated form of the 
enzyme (i.e. Activated ALP–Taurine Complex). 
Researchers have demonstrated taurine can protect 
tissues from neutrophil-induced reperfusion injury and 
oxidative stress because the respiratory burst activity of 
neutrophils is also significantly reduced in the presence 
of taurine (Raschke et al., 1995). Also, exposure to 
bacterial endotoxins has been suggested as one factor 
which can augment the magnitude of individual 
responses to xenobiotics (Roth et al., 1997). Circulating 
endotoxins of intestinal origin have been found to create 
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gut, stimulating increases in serum endotoxin levels. In 
experimental animals, taurine was found to significantly 
inhibit intestinal translocation and to protect the animals 
from endotoxemic injury (Roth et al., 1997). Therefore, it 
is possible that taurine might be able to modify factors 
underlying susceptibility to toxic substances since it has 
been reported that taurine’s protective effect is mediated 
by its antioxidative properties (Raschke et al., 1995).  
 
Though it is known that lipopolysaccharide (LPS) 
induces apoptosis and inhibits osteoblast differentiation 
(Guo et al., 2014), it has however been reported that 
pre-treatment with rutin, an anti-inflammatory agent like 
taurine, inhibited LPS-induced neutrophil infiltration in 
the lungs, LPS-induced expression of vascular cell 
adhesion molecule (VCAM)-1 and inducible nitric oxide 
synthase (iNOS) (Huang et al., 2014). Taurine, a non-
protein sulfur containing amino acid, is the most 
abundant free amino acid and has been shown to play 
several essential roles in the human body. It is widely 
distributed in very high concentrations in brain, heart, 
kidney, lens, and reproductive organs (Huxtable, 1992). 
In these tissues, it functions as an anti-inflammatory 
substance, neurotransmitter, cell volume regulator, 
antioxidant, growth promoting factor, etc. At the cellular 
level, one of its important functions is cytoprotection as 
demonstrated in this study. 
 
The enzyme activity decreased in the presence of 60 
mM L-phenylalanine. This shows that L-phenylalanine 
inhibit the rat intestinal alkaline phosphatase, which is in 
conformity with earlier studies on L-phenylalanine 
(Fishman et al.,1962; Arise et al., 2008). There was an 
evidence of inactivation of ALP exposed to L-
phenylalanine. There was reduction of ALP activity by 
60% in the presence of 60 mM L-phenylalanine. The 
inactivation of ALP by L-phenylalanine is also Km 
dependent as depicted by high Km value of 0.6 mM.  
This revealed that the binding affinity of ALP for p- NPP 
gradually reduced in the presence of 60 mM L-
phenylalanine. The mechanism of uncompetitive 
inhibition by L-phenylalanine was linked to its ability to 
bind to an arginine residue in the active site of the 
enzyme (Hoylaerts et al., 1992). 
 
Mg2+ and taurine are required for ALP activation.  When 
10 mM taurine and 40 mM Mg2+ was combined together, 
there was a positive synergisitic effect. There was an 
increase in Vmax and decrease in Km. This shows a high 
binding affinity of the enzyme to its substrate. This may 
be due to the fact that magnesium and taurine may have 
occupied the structural site on ALP that led to a 
subsequent conformational change from less active form 
of ALP to a more activated form of the enzyme (i.e. 
activated ALP - Mg2+ - taurine complex).  In the presence 
of 10 mM taurine, activation of the rat intestinal ALP 
activity occurred. This may be due to the activatory 
ability of taurine on L-phenylalanine inhibited rat 
intestinal ALP. The enzyme activity and Vmax increased 
compared to only L-phenylalanine inhibited rat intestinal 
ALP.  This revealed the modulatory ability of taurine on 
L-phenylalanine inhibition of rat intestinal ALP. Taurine 
relieved L-phe inhibition of rat intestinal ALP. This may 
explain some of the roles of ALP physiologically 
regardless of the inhibitory role of L-phenylalanine, which 
is believed to have some roles in inflammatory response 
and a component of FMLP, the most potent chemo 
attractant for phagocytic leukocytes (Marasco et al., 
1984).  Trachtman et al. (1992) proposed that the 
cytoprotective activity of taurine must be related in part 
to the scavenging of HOCl. However, the effects of 
taurine may also include the suppression of neutrophil 
activity by N-chlorotaurine and in this regard; Trachtman 
et al. (1992) found that a number of other reactive 
oxygen species and free radicals are produced during 
the inflammatory response. The activated ALP- taurine 
complex has a low Km which shows that taurine up-




This study shows that the hydrolysis of p-NPP and LP by 
rat intestinal ALP can be stimulated by taurine. The 
effect of taurine and magnesium on p-NPP hydrolysis as 
well as LP dephosphorylation by rat intestinal ALP is 
positively synergistic because of the increased Vmax. The 
activation of rat intestinal ALP by taurine may be one of 
the mechanisms of endotoxemic injury protection. The 
increased ALP activity mediated by taurine in the 
presence of L-phenylalanine may be an alternative 
immunological mechanism against endotoxemic injury. 
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